Literature DB >> 7637008

Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis.

A S Muerhoff1, T P Leary, J N Simons, T J Pilot-Matias, G J Dawson, J C Erker, M L Chalmers, G G Schlauder, S M Desai, I K Mushahwar.   

Abstract

The genomes of two positive-strand RNA viruses have recently been cloned from the serum of a GB agent-infected tamarin by using representational difference analysis. The two agent, GB viruses A and B (GBV-A and GBV-B, respectively), have genomes of 9,493 and 9,143 nucleotides, respectively, and single large open reading frames that encode potential polyprotein precursors of 2,972 and 2,864 amino acids, respectively. The genomes of these agents are organized much like those of other pestiviruses and flaviviruses, with genes predicted to encode structural and nonstructural proteins located at the 5' and 3' ends, respectively. Amino acid sequence alignments and subsequent phylogenetic analysis of the RNA-dependent RNA polymerases (RdRps) of GBV-A and GBV-B show that they possess conserved sequence motifs associated with supergroup II RNA polymerases of positive-strand RNA viruses. On the basis of similar analyses, the GBV-A- and GBV-B-encoded helicases show significant identity with the supergroup II helicases of positive-strand RNA viruses. Within the supergroup II RNA polymerases and helicases, GBV-A and GBV-B are most closely related to the hepatitis C virus group. Across their entire open reading frames, the GB agents exhibit 27% amino sequence identity to each other, approximately 28% identity to hepatitis C virus type 1, and approximately 20% identity to either bovine viral diarrhea virus or yellow fever virus. The degree of sequence divergence between GBV-A and GBV-B and other Flaviviridae members demonstrates that the GB agents are representatives of two new genera within the Flaviviridae family.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637008      PMCID: PMC189418     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

2.  Nucleotide sequence and genome organization of carnation mottle virus RNA.

Authors:  H Guilley; J C Carrington; E Balàzs; G Jonard; K Richards; T J Morris
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

3.  Characterization of marmoset hepatitis virus.

Authors:  W P Parks; J L Melnick; W R Voss; D B Singer; H S Rosenberg; J Alcott; A M Casazza
Journal:  J Infect Dis       Date:  1969-11       Impact factor: 5.226

Review 4.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

5.  Morphology of the GB hepatitis agent.

Authors:  J D Almeida; F Deinhardt; A W Holmes; D A Peterson; L Wolfe; A J Zuckerman
Journal:  Nature       Date:  1976-06-17       Impact factor: 49.962

6.  Hepatitis in marmosets.

Authors:  F Deinhardt; D Peterson; G Cross; L Wolfe; A W Holmes
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

7.  Studies of GB hepatitis agent in tamarins.

Authors:  P Karayiannis; L M Petrovic; M Fry; D Moore; M Enticott; M J McGarvey; P J Scheuer; H C Thomas
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

8.  Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions.

Authors:  F Deinhardt; A W Holmes; R B Capps; H Popper
Journal:  J Exp Med       Date:  1967-04-01       Impact factor: 14.307

9.  Molecular cloning and nucleotide sequence of the pestivirus bovine viral diarrhea virus.

Authors:  M S Colett; R Larson; C Gold; D Strick; D K Anderson; A F Purchio
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

10.  Molecular and serologic analysis in the transmission of the GB hepatitis agents.

Authors:  G G Schaluder; G J Dawson; J N Simons; T J Pilot-Matias; R A Gutierrez; C A Heynen; M F Knigge; G S Kurpiewski; S L Buijk; T P Leary
Journal:  J Med Virol       Date:  1995-05       Impact factor: 2.327

View more
  62 in total

1.  Investigation of HGV and TTV infection in sera and saliva from non-hepatitis patients with oral diseases.

Authors:  Jie Yan; Li-Li Chen; Yong-Liang Lou; Xiao-Zhi Zhong
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

2.  Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus.

Authors:  B Beames; D Chavez; B Guerra; L Notvall; K M Brasky; R E Lanford
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  A B C d e f g ...

Authors:  S Shafran; J Conly
Journal:  Can J Infect Dis       Date:  1996-05

4.  Relation between GB virus C/hepatitis G virus and fulminant hepatic failure may be secondary to treatment with contaminated blood and/or blood products.

Authors:  R Halasz; L Barkholt; C Lara; C Hultgren; Y Ando; U Broomé; B Fischler; A Nemeth; B G Ericzon; A Sönnerborg; M Sällberg
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

5.  Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organization.

Authors:  J N Simons; S M Desai; D E Schultz; S M Lemon; I K Mushahwar
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

Review 6.  Immunodiagnosis of viral hepatitides A to E and non-A to -E.

Authors:  G Yang; G N Vyas
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

7.  A reevaluation of the higher taxonomy of viruses based on RNA polymerases.

Authors:  P M Zanotto; M J Gibbs; E A Gould; E C Holmes
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  Species-specific variants of GB virus A in captive monkeys .

Authors:  T P Leary; S M Desai; J Yamaguchi; M L Chalmers; G G Schlauder; G J Dawson; I K Mushahwar
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

9.  Molecular evolution of GB virus B hepatitis virus during acute resolving and persistent infections in experimentally infected tamarins.

Authors:  Shingo Takikawa; Ronald E Engle; Kristina N Faulk; Suzanne U Emerson; Robert H Purcell; Jens Bukh
Journal:  J Gen Virol       Date:  2009-11-11       Impact factor: 3.891

10.  Modulation of GB virus B RNA abundance by microRNA-122: dependence on and escape from microRNA-122 restriction.

Authors:  Selena M Sagan; Peter Sarnow; Joyce A Wilson
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.